These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26514537)

  • 21. Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study.
    Jacob J; Belin L; Pierga JY; Gobillion A; Vincent-Salomon A; Dendale R; Beuzeboc P; Campana F; Fourquet A; Kirova YM
    Breast Cancer Res Treat; 2014 Nov; 148(2):345-53. PubMed ID: 25318926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.
    Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A
    Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
    Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
    Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of extracapsular invasion of axillary lymph nodes combined with peritumoral vascular invasion in patients with breast cancer.
    Yajima R; Fujii T; Yanagita Y; Fujisawa T; Miyamoto T; Hirakata T; Tsutsumi S; Iijima M; Kuwano H
    Ann Surg Oncol; 2015 Jan; 22(1):52-8. PubMed ID: 25059790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eight Year Survival Analysis of Patients with Triple Negative Breast Cancer in India.
    Chandra D; Suresh P; Sinha R; Azam S; Batra U; Talwar V; Kumar K; Mehta A
    Asian Pac J Cancer Prev; 2016; 17(6):2995-9. PubMed ID: 27356724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of triple-negative versus non-triple-negative breast cancers managed with breast-conserving therapy.
    Bhatti AB; Khan AI; Siddiqui N; Muzaffar N; Syed AA; Shah MA; Jamshed A
    Asian Pac J Cancer Prev; 2014; 15(6):2577-81. PubMed ID: 24761867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
    Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
    Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for male breast cancer: similarity to female counterparts.
    Yu E; Stitt L; Vujovic O; Joseph K; Assouline A; Au J; Younus J; Perera F; Tai P
    Anticancer Res; 2013 May; 33(5):2227-31. PubMed ID: 23645780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors associated with locoronal relapses, metastatic relapses, and death among women with breast cancer. Population-based cohort study.
    Osmani F; Hajizadeh E; Rasekhi A; Akbari ME
    Breast; 2019 Dec; 48():82-88. PubMed ID: 31568898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors for supraclavicular lymph node recurrence in N1 breast cancer patients.
    Kong M; Hong SE
    Asian Pac J Cancer Prev; 2013; 14(4):2509-14. PubMed ID: 23725165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive factors of survival time of breast cancer in kurdistan province of Iran between 2006-2014: a cox regression approach.
    Karimi A; Delpisheh A; Sayehmiri K; Saboori H; Rahimi E
    Asian Pac J Cancer Prev; 2014; 15(19):8483-8. PubMed ID: 25339051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors Affecting Long-Survival of Patients with Breast Cancer by Non-Mixture and Mixture Cure Models Using the Weibull, Log-logistic and Dagum Distributions: A Bayesian Approach.
    Rafati S; Baneshi MR; Bahrampour A
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):485-490. PubMed ID: 32102528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases.
    Akbari ME; Rohani- Rasaf M; Nafissi N; Akbari A; Shojaee L
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):949-953. PubMed ID: 29693352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival.
    Ulas A; Kos T; Avci N; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    Asian Pac J Cancer Prev; 2015; 16(4):1643-9. PubMed ID: 25743846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
    Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
    Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Affecting Long-Survival of Patients with Esophageal Cancer Using Non-Mixture Cure Fraction Model.
    Zarean E; Azizmohammad Looha M; Amini P; Mahmoudi M; Azimi T
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1677-1683. PubMed ID: 29938465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of circulating tumor cells in breast cancer patients: prognostic predictive role.
    Turker I; Uyeturk U; Sonmez OU; Oksuzoglu B; Helvaci K; Arslan UY; Budakoglu B; Alkis N; Aksoy S; Zengin N
    Asian Pac J Cancer Prev; 2013; 14(3):1601-7. PubMed ID: 23679243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nodal ratio of positive to excised nodes, but not number of positive lymph nodes is better to predict group to avoid chemotherapy among postmenopausal ER-positive, lymph node-positive T1-T2 breast cancer patients.
    Jia XQ; Hong Q; Cheng JY; Li JW; Wang YJ; Mo M; Shao ZM; Shen ZZ; Liu GY
    J Cancer Res Ther; 2015; 11(4):740-5. PubMed ID: 26881511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.